Semaglutide in India: the brands, who makes them, what each is approved for, and what is not sold here

Semaglutide injection is approved in India for type 2 diabetes (Ozempic, Extensior and several generics) and for chronic weight management (Wegovy, Poviztra and Noveltreat)^{5,7,8,14,17,20}. For the weight use, Zydus's filing names adults whose starting BMI is 30 or above, or 27 or above with a weight-related condition³⁴. Reviewing tirzepatide in June 2026, CDSCO's committee noted that obesity and overweight are defined differently in US and Asian populations, yet kept the BMI cut-offs in its Indian indication³⁵.

Yes. Wegovy has been on sale since 24 June 2025, three years after its approval on 20 April 2022^4,5. Ozempic followed on 12 December 2025, and generic brands launched the weekend the patent ended, 20 March 2026^6,11. Tablets are sold as Rybelsus, as Torrent's Semalix and Sembolic, and as Dr Reddy's Obeda since 20 May 2026^9,10,25. Wegovy in India tracks the two Novo Nordisk brands.

Three products are not sold here. The Wegovy pill, a 25 mg daily tablet approved in the US for weight reduction, has no Indian approval found^3,29. In September 2026, CDSCO's committee asked Novo Nordisk India for more data (Medical Dialogues)³⁰. Orforglipron, a daily GLP-1 tablet approved as Foundayo in the US, had a positive CDSCO committee recommendation in June 2026 and no Indian launch found^31,32. Generic tirzepatide is not sold here: a Bloomberg report of April 2026 said tirzepatide was still under patent³³. Its brands, Mounjaro and Yurpeak, are covered on Mounjaro in India^36,37.

The Indian semaglutide patent expired on 20 March 2026, and generic brands launched the same weekend¹¹. Their approvals differ: in January 2026, CDSCO's committee recommended MSN's and Natco's injections and Torrent's tablets for adults whose type 2 diabetes was insufficiently controlled, and not for weight management¹⁷. Zydus says India's drug controller (DCGI) approved its injection for type 2 diabetes and obesity, and Alkem says the same for its three brands^21,24.

In July 2026 three companies recalled select batches. Torrent recalled select Semalix pens in 2 mg and 4 mg, made by Dr Reddy's, after Dr Reddy's found a quality issue²⁶. Dr Reddy's recalled select Obeda batches with an impurity associated with the active ingredient, and USV recalled batches of its semaglutide brand Usema, according to industry sources¹². Torrent said there was no risk to patients now on treatment, and Dr Reddy's reported no patient safety concerns^12,26. Your pharmacist or doctor can look at any pack that worries you.

Which semaglutide brands does Sun Pharma sell?

Sun Pharma sells Noveltreat, a pre-filled pen in five strengths for chronic weight management, and Sematrinity, a multi-dose pen (one that holds several doses) for type 2 diabetes²⁰. CDSCO's committee recommended Sun's semaglutide tablets in 3, 7 and 14 mg for type 2 diabetes in June 2026; their launch is not in our sources³⁵.

Which semaglutide brands does Natco sell?

Natco sells Semanat and Semafull in multi-dose vials of 2 mg/1.5 ml and 4 mg/3 ml (March 2026) and 8 mg/3 ml (April 2026)^16,38. CDSCO's committee recommended Natco's injection for type 2 diabetes in January 2026, after it accepted a Phase III trial report¹⁷. Every generic brand by maker is listed on GLP-1 medicines in India.

Pens, vials and reusable cartridge pens are on sale, so if you change brand, you may also change device. Wegovy, Poviztra, Noveltreat and Obeda are pens, in the strengths of the table above^7,19,20,39. The US label says the US Wegovy 2.4 mg pen holds 4 weekly doses³. Natco's and Eris's brands come in multi-dose vials, and Glenmark's Glipiq as a vial or a pre-filled pen^16,18,23. Zydus's reusable pen takes a 15 mg/3 ml cartridge, and Alkem offers a reusable pen in which only the cartridge is replaced^21,24.

Your doctor decides the brand, the dose and any change of device. PharmEasy says Wegovy pens are kept in a refrigerator at 2 to 8 °C before first use and never frozen; the US label gives the same range^3,40. The dose steps, taken from the US label, are on the semaglutide dose schedule page; the steps for a pen are on how to use semaglutide pen.

Yes, for type 2 diabetes. Novo Nordisk's Rybelsus comes in 3, 7 and 14 mg strips⁹. Torrent launched its Semalix and Sembolic tablets on 21 March 2026 and describes itself as India's first company to launch generic oral semaglutide²⁵. Dr Reddy's launched Obeda tablets on 20 May 2026; it says CDSCO approved them after a Phase III study in India of 288 people with type 2 diabetes¹⁰. Under the US label, Rybelsus is approved for type 2 diabetes and not for weight loss⁴¹. More on semaglutide tablets in India.

From 1 April 2026, Novo Nordisk cut its Indian prices, by an average of about 24 % for Ozempic and 27 % for Wegovy⁴². On 22 September 2025, GST on most medicines dropped to 5 % from 12 %⁴³. Every row keeps the unit its source used, so check the unit before you compare two rows.

Prices as reported on the dates shown, in the order of the table above^44,45. They are not an offer, and they change.

Facts checked on 29 October 2026. Extensior: no price in our sources. MRP means the maximum retail price on the pack.

PharmEasy lists every semaglutide brand in India as a Schedule H medicine, the class sold only on prescription, and says Wegovy and Ozempic cannot be bought over the counter^2,39. Who may write it is less settled: two government sources differ. The first, a health-ministry release of 24 March 2026, says the approval of GLP-1 weight-loss drugs came on condition that endocrinologists and internal medicine specialists prescribe them, and for some indications cardiologists only⁴⁸. The second, a government warning reported in March 2026, allows generic semaglutide to be sold only against a prescription from a registered medical practitioner⁴⁹. For Dr Reddy's oral semaglutide, CDSCO's committee observed that it is to be prescribed only by registered endocrinologists⁵⁰. This page cannot resolve the difference; your doctor will know which condition applies to your brand.

An advisory that CDSCO sent every manufacturer on 10 March 2026 bans surrogate advertisements, which promote a product without naming it, and indirect promotion of GLP-1 weight-loss drugs that could mislead or encourage off-label use⁴⁸. By 24 March 2026, regulators had inspected 49 businesses, slimming clinics among them⁴⁸. Near New Delhi, Haryana's drug regulator was reported by Reuters in April 2026 to have seized more than 260 suspected counterfeit Mounjaro pens, an official claim Reuters could not verify⁵¹. A government backgrounder advises you to see a qualified medical specialist before use and to get these medicines only on prescription, from legitimate, regulated channels⁵². If you want to know whether semaglutide suits you, talk to a Zelta specialist.

What is the price of Ozempic 1 mg? ₹2,275 a week (₹9,100 a month) including taxes, Novo Nordisk India's price from 1 April 2026⁴⁶.

What is Ozempic used for? Type 2 diabetes, in India; the 2.4 mg weight-management dose is sold as Wegovy^2,14.

Is Ozempic another name for semaglutide? No, it is a brand name; semaglutide is the medicine inside it⁶.

Who manufactures Ozempic? Novo Nordisk⁶. Abbott announced a second brand, Extensior, in February 2026⁸.

Is Ozempic available again? Yes, in India: Ozempic has been on sale since 12 December 2025⁶.

Is Ozempic have semaglutide? Yes. Semaglutide is the medicine in Ozempic⁶.

Can semaglutide treat diabetes? Yes. Type 2 diabetes was its first approved use in India, as Rybelsus tablets, approved in 2020^5,13,14.

How much is semaglutide per mg? No Indian source we read prices it per mg; prices come per week, per pen, per month or per tablet, as in the table above^44,45.

How much will the new semaglutide pill cost? The Wegovy pill is not sold in India, so it has no Indian price^29,30.

How long does it take for semaglutide to work? Our sources give no Indian figure. Under the US label, the weight-loss dose rises over 16 weeks from 0.25 mg to 2.4 mg a week³. The Indian Wegovy, Poviztra and Noveltreat pens come in 2.4 mg^5,7,20. Trial results are on tirzepatide vs semaglutide.

What is liraglutide used for? Liraglutide is an older GLP-1 medicine; its Indian approved use is not in our sources. Pharmarack put its share of Indian GLP-1 sales at about 2 % in the year to April 2026¹.

Is Zepbound better than Ozempic? Zepbound is the US weight brand of tirzepatide; India sells tirzepatide as Mounjaro and Yurpeak^36,37,53. The comparison is on tirzepatide vs semaglutide.

• GLP-1 medicines in India: every brand by maker, with the recall detail.
• semaglutide tablets in India: Rybelsus and the generic tablets.
• Mounjaro in India: tirzepatide's brands, strengths and dated prices.
• Wegovy in India: where the two Novo Nordisk brands stand.
• semaglutide side effects: the trial rate of each side effect.